New Canadian Guideline Frames Statin Deprescribing for Adults 65 and Older
This first dedicated statin deprescribing guideline gives pharmacists a GRADE-based, patient-centred framework for the routine decision of whether to continue or stop statins in older adults.
statin deprescribing guidelineCanadian Family Physiciangeriatricsolder adultsprimary preventionsecondary preventionend of lifeHMG-CoA reductase inhibitorsGRADEGeriatrics / Geriatric Pharmacy
Background Information
New guideline supports personalized statin deprescribing for older adults.
Deprescribing statins for older adults requires careful consideration to balance risks and benefits, particularly at the end of life. The guideline suggests deprescribing statins in end-of-life situations while continuing them for primary or secondary prevention in other older adults. Recommendations are formed using the GRADE framework and emphasize individualized care decisions based on patient values, health goals, and clinical circumstances. Use patient-centered discussions to guide statin use in older adults.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Citation:Thompson W, Barry AR, McCarthy LM, et al. Deprescribing statins for adults 65 years of age and older: Evidence-based clinical practice guideline. Canadian family physician Medecin de famille canadien. 2026;72(9):534-545. doi:10.46747/cfp.7209534